ArticleZeitschrift fur Rheumatologie2024
Comparison of the efficacy and safety of olokizumab at different dosages in patients with active rheumatoid arthritis: a network meta-analysis of randomized controlled trials.
Young Ho Lee et al.PubMed ↗Publisher ↗
No numbers read from the abstract.